Interpreting cost-effectiveness ratios in a cost-effectiveness analysis of risk-tailored prostate screening: A critique of Callender et al.

por O'Mahony, James F.
Publicado 2020

Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs

por O’Mahony, James F.
Publicado 2021

Risk Stratification in Cost-Effectiveness Analyses of Cancer Screening: Intervention Eligibility, Strategy Choice, and Optimality

por O’Mahony, James F.
Publicado 2021

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice

por O’Mahony, James F., Newall, Anthony T., van Rosmalen, Joost
Publicado 2015

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R

por Lin, Yi-Shu, O’Mahony, James F, van Rosmalen, Joost
Publicado 2023

A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?

por Pokharel, Rajani, Lin, Yi-Shu, McFerran, Ethna, O’Mahony, James F.
Publicado 2023

Cost-Effectiveness Analyses of Lung Cancer Screening Using Low-Dose Computed Tomography: A Systematic Review Assessing Strategy Comparison and Risk Stratification

por Fabbro, Matthew, Hahn, Kirah, Novaes, Olivia, Ó’Grálaigh, Mícheál, O’Mahony, James F.
Publicado 2022

Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review

por Ekwunife, Obinna I., Grote, Andreas Gerber, Mosch, Christoph, O’Mahony, James F., Lhachimi, Stefan K.
Publicado 2015

Challenges in Cost-Effectiveness Analysis Modelling of HPV Vaccines in Low- and Middle-Income Countries: A Systematic Review and Practice Recommendations

por Ekwunife, Obinna I., O’Mahony, James F., Gerber Grote, Andreas, Mosch, Christoph, Paeck, Tatjana, Lhachimi, Stefan K.
Publicado 2016

Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Inte...

por McFerran, Ethna, O’Mahony, James F., Naber, Steffie, Sharp, Linda, Zauber, Ann G., Lansdorp-Vogelaar, Iris, Kee, Frank
Publicado 2022

Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability

por Almajed, Suaad, Alotaibi, Nora, Zulfiqar, Sana, Dhuhaibawi, Zahraa, O’Rourke, Niall, Gaule, Richard, Byrne, Caoimhe, Barry, Aaron M., Keeley, Dylan, O’Mahony, James F.
Publicado 2021

Cervical screening during the COVID-19 pandemic: optimising recovery strategies

por Castanon, Alejandra, Rebolj, Matejka, Burger, Emily Annika, de Kok, Inge M C M, Smith, Megan A, Hanley, Sharon J B, Carozzi, Francesca Maria, Peacock, Stuart, O'Mahony, James F
Publicado 2021

A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions

por Burger, Emily A, de Kok, Inge MCM, O'Mahony, James F, Rebolj, Matejka, Jansen, Erik EL, de Bondt, Daniel D, Killen, James, Hanley, Sharon J, Castanon, Alejandra, Regan, Mary Caroline, Kim, Jane J, Canfell, Karen, Smith, Megan A
Publicado 2022

Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions

por Burger, Emily A., de Kok, Inge M.C.M., O’Mahony, James F, Rebolj, Matejka, Jansen, Erik E.L., de Bondt, Daniel D., Killen, James, Hanley, Sharon J., Castanon, Alejandra, Kim, Jane J., Canfell, Karen, Smith, Megan A., Regan, Mary Caroline
Publicado 2022